---
aliases:
- (Figuracion et al., 2022)
author: Figuracion, Karl Cristie F. and Halasz, Lia M. and Lam, Ny-Ying and Goldberg,
  Myron and Stuckey, Joe and Failor, Richard A. and Knowles, Lindsey M. and Artherholt,
  Samantha and Chou, Brian and Francis, Courtney E. and Knight, Kristin and Kaur,
  Maninder and Sadak, Tatiana and McGranahan, Tresa
citekey: figuracion2022SurveillanceLongtermComplications
date_added: '2025-03-23'
doi: 10.1093/nop/npac053
journal: Neuro-Oncology Practice
title: Surveillance of Long-Term Complications after Treatment of Adult Brain Tumor
  Survivors-Review and Evidence-Based Recommendations
year: '2022'

---
# Surveillance of Long-Term Complications after Treatment of Adult Brain Tumor Survivors-Review and Evidence-Based Recommendations
- [PDF Link](zotero://open-pdf/library/items/DSL4BUPX)

Citation: [@figuracion2022SurveillanceLongtermComplications]

***
# TL;DR (Summary)
- 88,000 adults are diagnosed annually with primary brain tumors, and over 200,000 with secondary or metastatic brain tumors.
- More than 50% of patients receiving combined modality treatment develop treatment-induced hearing loss.
- The prevalence of depression among brain tumor survivors ranges from 15% to 28% within the first year, increasing to 38-42% post-treatment, with anxiety at 48%.
- Developed a comprehensive set of evidence-based recommendations for screening and managing long-term complications in adult brain tumor survivors, which is unique as most guidelines focus on childhood survivors.
- Utilized a multidisciplinary approach involving experts from various medical fields to create tailored screening tools and recommendations.
- Authors emphasize the necessity of routine screening for long-term complications to improve health and quality of life in adult brain tumor survivors.
- They suggest further research to document the incidence and prevalence of medical complications and evaluate the efficacy of screening and survivorship programs.
- The review highlights the lack of existing guidelines for adult brain tumor survivors, unlike those available for childhood survivors.
- Recommendations include annual screening for various complications such as cognitive dysfunction, vasculopathy, and endocrinopathy, tailored to the specific treatments received by patients.

# 中文摘要 (TL;DR)
- 每年有88,000名成人被診斷出患有原發性腦瘤，超過200,000名被診斷出患有繼發性或轉移性腦瘤。
- 接受聯合治療方式的患者中，超過50%會發展出治療誘導的聽力損失。
- 在腦瘤倖存者中，第一年內抑鬱的患病率範圍從15%到28%，治療後增加到38-42%，焦慮率為48%。
- 開發了一套針對成人腦瘤倖存者長期併發症的篩查和管理的基於證據的建議，這是獨特的，因為大多數指南專注於兒童倖存者。
- 採用了多學科方法，涉及來自各個醫療領域的專家，創建了定制的篩查工具和建議。
- 作者強調對成人腦瘤倖存者進行常規篩查長期併發症的必要性，以改善健康和生活品質。
- 他們建議進一步研究以記錄醫療併發症的發生率和患病率，並評估篩查和倖存者計劃的有效性。
- 該評論強調了針對成人腦瘤倖存者的現有指南的缺乏，與針對兒童倖存者的指南不同。
- 建議包括針對認知功能障礙、血管病變和內分泌病變等各種併發症的年度篩查，根據患者接受的特定治療進行定制。
